Molecular targets for COVID-19 drug development: Enlightening Nigerians about the pandemic and future treatment [0.03%]
COVID-19药物开发的分子靶标：向尼日利亚人阐明大流行及其未来的治疗方向
Yusuf Muhammed
Yusuf Muhammed
There is little or no research initiated on enlightening Nigerians about the pathogenesis, targets for drug development and repositioning for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Coronavirus disease 2019 (...
Design of an air isolation and purification (AIP) desk for medical use and characterization of its efficacy in ambient air isolation and purification [0.03%]
用于医疗的空气隔离和净化(AIP)工作台的设计及其在环境空气中隔离和净化功效的特性分析
Tiantian Liu,Yubing Guo,Mei Wang et al.
Tiantian Liu et al.
The incidences of nosocomial infections (NIs) are increasing throughout the world, especially for those airborne diseases caused by pathogens or air particulates that float in air. In this study, we designed and manufactured a desk for clin...
Aihua Jin,Benyong Yan,Wei Hua et al.
Aihua Jin et al.
This study aimed to determine the clinical characteristics of patients diagnosed with the coronavirus disease 2019 (COVID-19). Clinical data of COVID-19 patients diagnosed between January 28, 2020 and February 23, 2020 at the Beijing You'an...
Assessment of the SARS-CoV-2 basic reproduction number, R 0, based on the early phase of COVID-19 outbreak in Italy [0.03%]
基于意大利新冠肺炎早期爆发阶段的基本再生数R0的评估
Marco D&#x;Arienzo,Angela Coniglio
Marco D&#x;Arienzo
As of March 12th Italy has the largest number of SARS-CoV-2 cases in Europe as well as outside China. The infections, first limited in Northern Italy, have eventually spread to all other regions. When controlling an emerging outbreak of an ...
Single virus tracking of Ebola virus entry through lipid rafts in living host cells [0.03%]
通过脂筏在活宿主细胞中对埃博拉病毒进入过程的单个病毒追踪
Cong Jin,Bin Che,Zhengyuan Guo et al.
Cong Jin et al.
Ebola virus (EBOV) is one of the most pathogenic viruses in humans which can cause a lethal hemorrhagic fever. Understanding the cellular entry mechanisms of EBOV can promote the development of new therapeutic strategies to control virus re...
William J Liu,Weifeng Shi,Wuyang Zhu et al.
William J Liu et al.
The onsite next generation sequencing (NGS) of Ebola virus (EBOV) genomes during the 2013-2016 Ebola epidemic in Western Africa provides an opportunity to trace the origin, transmission, and evolution of this virus. Herein, we have diagnose...
Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo [0.03%]
评估抗filovirus单克隆抗体体内疗效的病毒接种和治疗方案
Logan Banadyga,Zachary Schiffman,Shihua He et al.
Logan Banadyga et al.
The development of monoclonal antibodies to treat disease caused by filoviruses, particularly Ebola virus, has risen steeply in recent years thanks to several key studies demonstrating their remarkable therapeutic potential. The increased d...
National Health Commission Of The People&#x;s Republic Of China
National Health Commission Of The People&#x;s Republic Of China
George F Gao
George F Gao
Biological threats, whether naturally occurring, accidental, or deliberate in origin, can result in disasters that are regional, national, or even global in scope if not properly contained. Many global communities, international programs, a...
A strategy to prevent future epidemics similar to the 2019-nCoV outbreak [0.03%]
防止类似2019-nCoV冠状病毒未来流行的战略
Peter Daszak,Kevin J Olival,Hongying Li
Peter Daszak
A novel bat-origin coronavirus emerged in Wuhan, China in December 2019 and continues to spread across China and the world. At the time of writing, a massive global response has been implemented to control the disease as it spreads from per...